Table:
begin	end	state
1	29	non-cytoplasmic
30	50	transmembrane
51	56	cytoplasmic
57	79	transmembrane
80	84	non-cytoplasmic
85	116	transmembrane
117	126	cytoplasmic
127	150	transmembrane
151	177	non-cytoplasmic
178	200	transmembrane
201	229	cytoplasmic
230	251	transmembrane
252	283	non-cytoplasmic
284	304	transmembrane
305	364	cytoplasmic
365	395	transmembrane
396	414	non-cytoplasmic
415	448	transmembrane
449	596	cytoplasmic

Input:
>RR42_RS16025 FitnessBrowser__Cup4G11:RR42_RS16025
MRQPFPLAAFHPRLLDSLRDYNRALFFKDLAAGLTVGVVALPLAMAFAIASGMPPQAGLF
TAIIAGFLIAALGGSPVQIGGPAGAFIVIVYGIVARYGVANLLIATILAGGLLFAMGLFR
LGTLIRFIPVAIVIGFTNGIAVLIMVSQIADFLGLQTGKLPGNFLSQMRVLGRALPTVSW
PTVALAVSSLVVVAGWSRLALLAGKRWRPVSTVAANPANPPNAHGRLGRALAMVPGTVIA
LVLATAANGLLHLPVETIGTRFGGIPQGLPPFALPQLSWQLVQQLVAPTLTIALLGAIES
LLCARVADSLIDDRHDPNQELMAQGIANIVTPFFGGLPATGTIARTVTNVRSGGRTPVAG
MIHAATLLLIVLVAAPLASAIPLATLAAILLYVAWNMGEWHMFGLTHLKRYSNNYRIILL
GTFVLTVVFDLTVAVQVGLVLACLFFIYRMAALTQIEAIAPAALPPAADGRPLPAGEVAA
YHMTGALFFGAVNKVEALIDPRDRTQPVPAVLILDVGKLVALDTTGLDTLDALRKTLARR
GGTLVICAAPAQVMSLMRRAGFLEQMGTANYCDTLAAACARAGVLLAERAERPAAG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server